Vanguard Group Inc Arcutis Biotherapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,962,635 shares of ARQT stock, worth $72.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,962,635

Previous 6,144,290 13.32%

Holding current value

$72.9 Million

Previous $57.1 Million 13.32%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$8.32 - $11.0 $6.81 Million - $9 Million	818,345 Added 13.32%	6,962,635 $64.8 Million
Q2 2024 Aug 13, 2024	BUY	$7.24 - $12.53 $7.08 Million - $12.3 Million	977,873 Added 18.93%	6,144,290 $57.1 Million
Q1 2024 May 10, 2024	BUY	$3.25 - $11.77 $877,188 - $3.18 Million	269,904 Added 5.51%	5,166,417 $51.2 Million
Q4 2023 Feb 14, 2024	BUY	$1.84 - $4.82 $3.71 Million - $9.72 Million	2,017,053 Added 70.05%	4,896,513 $15.8 Million
Q3 2023 Nov 14, 2023	BUY	$5.31 - $10.98 $1.22 Million - $2.52 Million	229,072 Added 8.64%	2,879,460 $15.3 Million
Q2 2023 Aug 14, 2023	BUY	$7.51 - $15.0 $512,610 - $1.02 Million	68,257 Added 2.64%	2,650,388 $25.3 Million
Q1 2023 May 15, 2023	BUY	$10.23 - $17.14 $518,855 - $869,323	50,719 Added 2.0%	2,582,131 $28.4 Million
Q4 2022 Feb 10, 2023	BUY	$13.96 - $20.4 $3.89 Million - $5.68 Million	278,473 Added 12.36%	2,531,412 $37.5 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $8.11 Million - $12.2 Million	454,276 Added 25.26%	2,252,939 $43.1 Million
Q2 2022 Aug 12, 2022	BUY	$16.33 - $22.2 $4.37 Million - $5.94 Million	267,565 Added 17.48%	1,798,663 $38.3 Million
Q1 2022 May 13, 2022	BUY	$14.38 - $22.79 $241,152 - $382,188	16,770 Added 1.11%	1,531,098 $29.5 Million
Q4 2021 Feb 14, 2022	BUY	$14.98 - $25.5 $331,372 - $564,085	22,121 Added 1.48%	1,514,328 $31.4 Million
Q3 2021 Nov 12, 2021	SELL	$19.28 - $27.1 $39,890 - $56,069	-2,069 Reduced 0.14%	1,492,207 $35.6 Million
Q2 2021 Aug 13, 2021	BUY	$24.42 - $34.75 $36.5 Million - $51.9 Million	1,494,276 New	1,494,276 $40.8 Million

Others Institutions Holding ARQT

# of Institutions

200

Shares Held

129M

Call Options Held

729K

Put Options Held

257K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $630M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Arcutis Biotherapeutics, Inc. Transaction History